Eminent Australian Prof David Thomas delivers MPCCC’s March Precision Oncology Seminar

2019-03-22T10:34:29+00:00 March 22nd, 2019|

From left-right: Vikki Marshall (Project Manger - Precision Oncology Program), Prof David Thomas, Prof Mark Shackleton, Glenn Cartwright (Strategy Manager - Precision Oncology Program). Prof [...]

Change is on the Horizon as MPCCC Research Director Resigns and MCCC is Retired

2019-03-18T15:43:42+00:00 March 18th, 2019|

After over nine years dedicated to developing collaborative cancer research platforms across Monash University, Prof Gail Risbridger this month announced her resignation from the role [...]

MPCCC Tele-trials Pilot to Increase Access to Clinical Trials for People in the Gippsland Region

2019-01-25T08:51:41+00:00 January 25th, 2019|

A new MPCCC tele-trials pilot project will reduce the need for people with cancer to travel to large metropolitan centres in Melbourne to undertake trial-related [...]

Collaborative Care Model to Expand Services for Patients with Cancer-Related Depression

2018-07-04T13:14:08+00:00 July 4th, 2018|

Monash Partners Comprehensive Cancer Consortium (MPCCC) is to pilot an innovative model of care enabling cancer patients with depression to have improved access to psychology [...]

Treatment for Cancer Patients to Improve with MPCCC’s New Precision Oncology Tumour Board

2018-07-04T13:18:41+00:00 May 11th, 2018|

Cancer patients treated at Monash Partners’ hospitals will have equitable access to the latest precision medicine technologies, and the best medical advice and treatments thanks [...]